Common Cold Epidemiology Forecast 2025-2034

Some estimates suggest that people in the United States experience nearly 1 billion colds in a year. The Centers for Disease Control and Prevention (CDC) also states that 22 million school days are lost each year in the country due to the common cold.

Common Cold Epidemiology Forecast Report Coverage

The “Common Cold Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of the common cold. It projects the future incidence and prevalence rates of the common cold across various populations. The study covers age and type as major determinants of the common cold-affected population. The report highlights patterns in the prevalence of common cold over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of Common Cold in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Common Cold: Disease Overview

The common cold is a contagious viral infection that affects the upper respiratory tract including the nose, throat, sinuses, and windpipe. It can be caused by different types of viruses. The symptoms of common cold usually appear in 3 stages (early, active, and late). Children and babies are more prone to common colds as they haven’t been exposed to as many viruses as adults. A runny nose, sneezing, loss of appetite, and a fever are some of the symptoms of colds in babies.

Common Cold: Treatment Overview

There is no cure for colds, and they usually go away within 7 to 10 days without turning into anything serious. Over-the-counter (OTC) medications can help to manage symptoms. Pain relievers such as acetaminophen (Tylenol®) and NSAIDs (ibuprofen (Advil®)) aid in relieving fever and headaches. Decongestants like pseudoephedrine (Contac Cold 12 Hour® and Sudafed®) are widely used for symptom relief. Expectorants like Guaifenesin (Mucinex®) may help to thin and loosen mucus.

Epidemiology

The common cold epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for the common cold by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for the common cold and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• As per the American Lung Association, an adult experiences 2 to 3 colds a year, especially between September and May.
• Research shows that over 200 different viruses can cause a common cold, with rhinoviruses responsible for nearly 50% of common colds.
• According to a review article published in the Frontiers in Allergy (2023), the incidence of the common cold has an inverse correlation with age, with infants suffering from 6 to 8 colds a year in contrast to adults experiencing 2 to 4 colds annually.
• Studies suggest that women, particularly those between the ages of 20 and 30, experience more colds than men, possibly due to their closer contact with children.

Country-wise Common Cold Epidemiology

The common cold epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of the common cold varies significantly between countries due to differences in cultural practices, such as social behaviors and hygiene, healthcare access, population density, and climate, as weather conditions influence viral survival and spread. In India, it is estimated that people typically experience the common cold twice a year, with nearly 40% to 50% of new cases recorded annually.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of common cold based on several factors.
• Common Cold Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of the common cold are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of common cold epidemiology in the 8 major markets?
• What will be the total number of patients with common cold across the 8 major markets during the forecast period?
• What was the country-wise prevalence of the common cold in the 8 major markets in the historical period?
• Which country will have the highest number of common cold patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of the common cold during the forecast period of 2025-2034?
• What are the currently available treatments for the common cold?
• What are the disease risks, signs, symptoms, and unmet needs of the common cold?

This product will be delivered within 3-5 business days.